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Pelvic organ prolapse (POP) is a bulge or protrusion into or 
through the vagina of pelvic organs and associated vaginal seg-
ments [1]. With the aging population, POP is an increasingly com-
mon condition seen in women with a lifetime prevalence of 30% 
to 50% [1,2]. Symptomatic urogenital prolapse has been shown 
to have significant negative impacts such as those relating to 
the lower urinary tract, fecal incontinence, back pain, pelvic pain, 
defecatory problems, and dyspareunia. Management options for 
women with symptomatic POP include observation, pelvic floor 
muscle training, mechanical support (pessaries), and surgery. A 
patient’s perception of discomfort from POP and subsequent treat-
ment will vary in relation to the stage of the POP and her ethnic-
ity. Currently, many surgical approaches have been introduced to 
correct POP. The life time risk of undergoing surgery was estimated 
to be between 11% and 19%. However, none of these techniques 
is without risks for complications [2-4]. The prevalence of reopera-
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Objective
The aim of this study was to report subjective and objective outcomes and to compare complication and recurrence rate in patients 
undergoing surgery for International Continence Society (ICS) stage 4 prolapse compared to ICS stage 2 or 3 prolapse. 
Methods 
We retrospectively reviewed the records of all patients having had surgical treatment for ICS Pelvic Organ Prolapse Quantification 
(POP-Q) stage 2-4 prolapse between January 2007 and December 2010 at the Yonsei University Severance Hospital. Only patients 
with ICS POP-Q stage 2-4 prolpase undergoing obliterative procedures or anti-incontinence surgery only were excluded. 
Results
Three hundred ninety nine patients met inclusion criteria, including 23 with stage 2, 239 with stage 3 and 137 with stage 4 
prolapse. The postoperative recurrence rate of preoperative stage IV was 2.4 times higher than that of stage III. There was a 
significantly higher incidence rates of perioperative and long-term complications, compared to women with other stage prolapse. 
The mean operative time was significantly greater in the stage 4 group compared to the stage 2, 3 group.
Conclusion 
The overall perioperative complication and recurrence rates in women undergoing surgery for pelvic organ prolapse are low. 
Women undergoing surgery for ICS POP-Q stage 4 prolapse were found to have a significantly greater blood loss and higher 
incidence rates of perioperative  complications and recurrence, compared with women of other stage.
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tion reported in some studies is high (43% to 56%) but probably 
overestimated as these studies included genital prolapse after 
Burch colposuspension [5,6]. Prevalence of reoperation for POP or 
urinary incontinence was 29.2% in a community-based population 
[2]. However data are lacking that compare perioperative, long-
term complications and recurrence rates of other stage prolapse, 
and very little is known about the factors associated with surgical 
failure. The aim of this study was to report subjective and objective 
outcomes and to compare complication rates in patients under-
going surgery for International Continence Society (ICS) stage 4 
prolapse compared to ICS stage 2, or 3 prolapse.
Materials and Methods
We retrospectively reviewed, using a computerized medical record 
database, all women (n = 399) who underwent surgical treatment 
for the for ICS Pelvic Organ Prolapse Quantification (POP-Q) stage 
2-4 prolapse in the Department of Obstetrics and Gynecology, 
Division of Female Pelvic Medicine and Reconstructive Surgery, 
Yonsei University Health System (Seoul, Korea) between Janu-
ary 2007 and December 2010. All patients provided a detailed 
urogynecologic and medical history, and underwent a compre-
hensive physical examination including the grading of prolapse 
utilizing the ICS POP-Q staging system by the same examiner and 
multichannel urodynamic testing when indicated. The surgical 
technique and combination of procedures were chosen after in-
formed consent from each patient, with the objective of correcting 
anatomic support of all prolapsed compartments. All procedures 
were performed by one senior surgeon. Patients with ICS POP-Q 
stage 2-4 prolpase undergoing obliterative procedures or anti-
incontinence surgery only were excluded. The study group was 
classified into 3 categories according to ICS POP-Q staging, 23 
women with stage 2; 239 women with stage 3; and 137 women 
with stage 4 prolapse. The date and indication for POP surgery 
were collected, as well as the route of POP surgery (abdominal, 
vaginal or laparoscopic) and the use of prosthetic material. The 
surgical techniques used in our institution for abdominal and vagi-
nal POP reconstruction were those described by Hirsch et al. Most 
of the procedures were conventional vaginal POP repairs without 
mesh, which were the techniques performed in our institution 
from 2005. Concomitant procedures such as urinary incontinence 
repair or hysterectomy were also identified. The patients who 
had had prolapse above stage 2 of the apical compartment were 
performed hysterectomy. Complications were subdivided into 
perioperative (within 2 month of the operation) and long-term (at 
least 2 month after the operation) complications. Perioperative 
and long-term complications, including estimated blood loss (EBL), 
blood transfusion, bladder injury, ureter injury, bowel injury, ureter 
obstruction, bowel obstruction, wound healing problem, urinary 
tract infection, urinary retention, urinary incontinence, voiding dif-
ficulty, mesh erosion, pelvic abscess, incisional hernia, and need 
to alter surgical procedure were evaluated. A blood loss ≥500 
mL was considered excessive. Patients were followed-up 1, 3, 6, 
and 12 months after surgery, and every year thereafter during the 
study period. At each visit, urinary/bowel symptoms and other 
problems were assessed. Changes in POP-Q stage and vaginal 
vault healing status were also examined. Data were reviewed on 
length of hospital stay, operation time, and difference between 
hemoglobin levels preoperatively and on the third postoperative 
day. Functional outcomes regarding urinary/bowel symptoms and 
anatomical recurrences were also assessed. Anatomical recurrence 
was defined as any prolapse equal to or greater than stage 2 of 
the POP-Q classification. 
1. Statistical analysis
Data analyses were performed by another professional who was 
blinded to the group allocation and had no knowledge of the 
interpretation of the results. The SPSS ver. 18.0 (IBM Co., Armonk, 
New York, NY, USA) was used for the statistical analyses. Baseline 
categorical variables were analyzed using chi square or Fisher’s 
exact test. Continuous variables were analyzed using the Wilcoxon 
rank sum test or the Krukal-Wallis test. A nominal two-sided P-value 
<0.05 was considered to indicate statistical significance.
Results
Three hundred ninety-nine patients met inclusion criteria, in-
cluding 23 (5.8%) with stage 2,239 (70.5%) with stage 3, and 
137 (34.3%) with stage 4 prolapse. The median postoperative 
follow-up time was 31.6 months, ranging from 3 to 47 months. 
Patients with prolapse stage 4 group were older than those in the 
stage 2, 3 groups but there was no statistical significance (mean 
age ± standard deviation [SD]: II, 62.6 ± 8.3 years; III, 63.4 ± 9.9 
years; IV, 66.5 ± 9.5 years; P=0.62). Patients of stage 4 group 
who had given vaginal birth had more prolpase than early stage 
groups, but also there was no significant differences. There was no 
significant difference in body mass index (BMI) (mean BMI±SD, 
24.5 ± 3.2 kg/m2), parity (mean parity, 3.3 ± 1.4), use of hormones 
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23/399 (5.8%), and menopause 366/399 (91.7%) (Table 1). 
The number of prior Cesarean section, hysterectomy and previ-
ous repair were similar among the three groups. The number of 
patients who underwent anterior colporrhaphy was 251 (II, 17 
[73.9%]; III, 170 [71.1%]; IV, 64 [46.7%]), posterior colporrhaphy 
(II, 21 [91.3%]; III, 229 [95.8%]; IV, 123 [89.8%]), abdominal 
hysterectomy (II, 0 [0%]; III, 33 [13.8%]; IV, 44 [32.1%]), vaginal 
hysterectomy (II, 2 [8.7%]; III, 60 [25.1%]; IV, 56 [40.9%]), lapa-
roscopic hysterectomy (II, 1 [4.4%], III, 3 [1.3%]; IV, 2 [1.5%]), 
vaginal vault suspension (II, 1 [4.4%]; III, 38 [15.9%]; IV, 23 
[16.8%]), abdominal sacrocolpopexy (II, 3 [13.0%]; III, 45 [18.8%]; 
IV, 60 [43.8%]), paravaginal repair (II, 2 [8.7%]; III, 34 [14.2%]; 
IV, 7 [5.1%]), midurethral sling (II, 11 [47.8%]; III, 86 [36.0%]; 
IV, 80 [58.4%]) (Table 2). Both the mean EBL and the number of 
patients with blood loss ≥500 mL was significantly greater in the 
stage 4 group compared to the stage 2, and 3 groups (mean ± SD: 
II, 116.1 ±175.0 mL; III, 162.9 ±177.5 mL; IV, 224.4 ±177.6 mL; 
P<0.0001). The number of perioperative transfusions (II, 0/23 [0%]; 
Table 1. Baseline characteristics 
Variable Stage II (n = 23) Stage III (n = 239) Stage IV (n = 137) P-value
Age (yr) 62.6 ± 8.3 63.4 ± 9.9 66.5 ± 9.5 NS
Body mass index (kg/m2) 24.7 ± 2.9 24.5 ± 2.9 24.6 ± 3.7 NS
Parity   3.2 ± 1.1   3.2 ± 1.4   3.6 ± 1.5 NS
Vaginal delivery   3.2 ± 1.2   3.3 ± 1.4   3.6 ± 1.6 NS
Menopause 23 213 130 NS
Hormone replacement therapy   2   15     7 NS
Prior Cesarean section   6   32   14 NS
Prioir hysterectomy   5   23   21 NS
Prior pelvic reconstruction surgery   3   19   11 NS
Values are presented as mean ± standard deviation or number (%).
NS, not significant. 
Table 2. Summary of surgical procedure
Procedure Stage II Stage III Stage IV P-value
Colporrhaphy
Anterior compartment 17 (73.9) 170 (71.1) 64 (46.7) <0.0001
Posterior compartment 21 (91.3) 229 (95.8) 123 (89.8) NS
Paravaginal repair 2 (8.7) 34 (14.2) 7 (5.1) 0.0220
Hysterectomy
Abdominal 0 (0) 33 (13.8) 44 (32.1) <0.0001
Vaginal 2 (8.7) 60 (25.1) 56 (40.9) 0.0004
Laparoscopic 1 (4.4) 3 (1.3) 4 (1.5) NS
The apical compartment
Sacrocolpopexy 3 (13.0) 45 (18.8) 60 (43.8) <0.0001
Vaginal vault suspensiona 1 (4.4) 38 (15.9) 23 (16.8) NS
Incontinence procedureb 11 (47.8) 86 (36.0) 80 (58.4)   0.0001
Others
Bilateral salpingo-oophorectomy 1 (4.4) 32 (13.4) 49 (35.8) <0.0001
Perineorrhaphy 22 (95.7) 220 (92.1) 130 (94.9) NS
Values are presented as number (%).
NS, not significant. 
aVaginal vault suspension included uterosacral vault suspension, sacrospinous vault suspension, and iliococcygeus vault suspension; bIncontinence pro-
cedure included mid urethral slings (TVT, Sparc) and transobturator slings (Monarc).
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III, 2/239 [0.8%]; IV, 6/137 [4.4%]) was similar among the three 
groups. The mean operative time was significantly greater in the 
stage 4 group compared to the stage 2, and 3 groups (mean ± SD: 
II, 84.7 ± 46.8 minutes; III, 111.2 ± 66.2 minutes; IV, 146.4 ± 58.4 
minutes; P<0.0001) (Table 3).
We evaluated 12 provisions of perioperative complications and 6 
of long-term complications. The incidences of perioperative and 
long-term complications are presented in Table 4. The overall 
complications in women undergoing surgery for POP were rare; 
most of them were transient and reversible. Two bladder injuries 
occurred in the stage 3 group from anterior and posterior col-
porrhaphy, abdominal sacrocolpopexy and transobturator tape 
(TOT) midurethral sling; one bladder injury occurred in the stage 
4 group from posterior colporrhaphy, abdominal sacrocolpopexy 
and TOT midurethral sling; and one ureter injury occurred in the 
stage 4 group from anterior and posterior colporrhaphy, vaginal 
hysterectomy, and TOT midurethral sling. There was a significantly 
higher incidence rate of perioperative and long-term complica-
Table 3. Perioperative parameters and complications
Parameters Stage II (n = 23) Stage III (n = 239) Stage IV (n = 137) P-value
Operation time (min) 84.7 ± 46.8 111.2 ± 66.2 146.4 ± 58.4 <0.0001
Estimated blood loss (mL) 116.1 ± 175.0   162.9 ± 177.5   224.4 ± 177.6 <0.0001
Difference between hemoblogin levels (g/dL) 1.6 ± 0.7   1.8 ± 0.9   1.9 ± 1.1 NS
Blood transfusion   0 (0)     2 (0.8)     6 (4.4) NS
Hospital stay (day) 6.6 ± 1.4   7.1 ± 2.4   7.4 ± 2.1   0.0195
Complications   1 (4.3)   12 (5.0)     18 (13.1) 0.015
Values are presented as mean ± standard deviation or number (%).
NS, not significant.  
Table 4. Perioperative, long-term complications and recurrence rates after vaginal prolapse surgery
Complication Stage II (n = 23) Stage III (n = 239) Stage IV (n = 137)
Perioperative (<2 mo)
Blood transfusion 0 (0) 2 (0.8) 6 (4.4)
Bladder injury 0 2 1
Ureter injury 0 0 1
Bowel injury 0 0 1
Ureter obstruction 0 0 1
Bowel obstruction 0 2 2
Urinary retention 1 1 2
Urinary incontinence 0 1 3
Urinary tract infection 0 1 2
Wound healing problem 0 0 4
Mesh erosion 0 1 0
Incisional hernia 0 0 0
Long-term (≥2 mo)
Urinary urgency 0 1 3
Urinary incontinence 0 1 3
Voiding dysfunction 0 0 1
Wound healing problem 1 1 0
Incisional hernia 0 0 1
Recurrence 1 (4.3) 9 (3.8) 13 (9.5)
Values are presented as number (%).
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tions, compared to women with other stage prolapse (perioperative 
complications: II, 1 [4.3%]; III, 5 [2.1%]; IV, 12 [8.8%]; P=0.010; 
long-term complications: II, 1 [4.3%]; III, 3 [1.3%]; IV, 8 [5.8%]; 
P=0.040). There was no significant difference in recurrence rates 
among the three groups (II, 1 [4.3%]; III, 9 [3.3%]; IV, 13 [9.3%]). 
However the postoperative recurrence rate of preoperative stage 4 
was 2.4 times higher than that of stage 3, which was statistically 
significant (P=0.02287). 
Regarding the access, the patients were operated on through 
various approaches; however there was no statistically significant 
difference according to the type of surgical approach. Hysterec-
tomy (vaginal, abdominal, and laparoscopic) or surgery for the 
apical compartment (sacrocolpopexy, vaginal vault suspension) 
did not increase operation time, or the risk of greater blood 
loss (mean ± SD; operation time: hysterectomy [201 women], 
145.9 ± 55.6 minutes; no hysterectomy [198 women], 97.2 ± 65.4 
minutes; surgery for apical compartment prolapse [170 wom-
en],155.2 ± 75.4 minutes; no surgery for apical compartment 
prolapse [229 women], 97.1± 42.4 minutes; EBL: hysterectomy, 
217.6 ±181.0 mL; no hysterectomy, 144.4 ±171.7 mL; surgery 
for apical compartment prolapsed, 306.0 ±168.7 mL; no surgery 
for apical compartment prolapsed, 88.7 ±123.6 mL) (Figs. 1, 2). 
History of abdominal operation or surgery for POP were also not 
associated with a higher risk of blood loss and longer opera-
tion time (mean ± SD; operation time: prior abdominal operation 
history [52 women], 114.3±60.6 minutes; no prior abdominal 
operation history [347 women], 122.4 ± 65.8 minutes; prior pelvic 
reconstruction (33 women), 130.1± 80.5 minutes; no prior pelvic 
reconstruction (366 women), 121.0 ± 63.8 minutes; EBL: prior ab-
dominal operation history, 127.6 ±185.9 mL; no prior abdominal 
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operation history, 186.0 ±179.1 mL; prior pelvic reconstruction, 
234.5 ± 205.6 mL; no prior pelvic reconstruction, 176.5 ±177.1 
mL) (Figs. 1, 2). There was no statistically significant difference ac-
cording to the prior abdominal operation history and pelvic recon-
struction. Figs. 1, 2 demonstrate direct comparisons among three 
groups. 
Discussion
In this study, we revealed that the POP-Q stage was the sole inde-
pendent risk factor for the complications after standard restorative 
pelvic reconstructive surgery. However, there is little knowledge of 
the risk factors preventing or promoting complications, recurrence, 
and consecutive reoperation [7]. Data arise from a few studies 
with few identified risk factors [7]. According to the previous stud-
ies, younger age, preoperative advanced stage, traumatic delivery, 
urinary incontinence, and previous pelvic reconstructive surgery 
are suggested as the risk factors for recurrence [8-11]. Whiteside 
et al. [9] studied 176 patients out of 389 who were observed for a 
year after vaginal reconstructive surgery to find that younger age 
(<60 years) was an important factor. A similar result was present-
ed by Nieminen et al. [11], who evaluated the risk factors of recur-
rence in patients who received sacrospinous ligament fixation. 
Diez-Itza et al. [12] suggested that younger women and women 
with a higher body weight are more likely to experience recurrent 
prolapse after vaginal repair with 228 women, (for 5-year follow-
up after surgery), while Nam et al. [13] suggested that obesity 
was a protective factor against blood loss and transfusion, and 
long-term urinary retention, diminished reserve could have been 
related to an adverse result. Prolapsed patients of a younger age 
were suspected of having a more pronounced tendency to present 
pathophysiology such as inferior tissue quality, and greater nerve, 
muscle, and fascial injury; but from another point of view, older 
patients were restricted from activity due to underlying medical 
problems [14]. 
The advanced preoperative stage (POP-Q stage III or IV) was an-
other risk factor, as seen in the study of Whiteside et al. [9]. Vakili 
et al. [10] reported that diminished levator ani and widened geni-
tal hiatus were related to the recurrent prolapse through a median 
5-month follow-up in 451 patients who received pelvic reconstruc-
tive surgery. Increasing size of genital hiatus is related to more ad-
vanced POP; this, too, shows that a preoperative advanced stage 
could result in recurrences [15]. Of 360 women who underwent 
POP surgery, Salvatore et al. [16] demonstrated that 36 women 
(10%) had a recurrent prolapse, and a preoperative vaginal de-
scent (more than stage 3) was the only significant risk factor, 
which is similar to our results. In our study, preoperative POP-Q 
stage 3 recurred more than stage 2 did, but the difference was not 
statistically significant. However, the postoperative recurrence rate 
of preoperative stage 4 was 2.4 times higher than that of stage 
3, which was statistically significant. In Tegerstedt and Hammar-
strom [8]’s study, univariate analysis showed that prolapsed stage 
4 adversely affects the outcome on both symptomatic and ana-
tomic recurrence, but not on the anatomic recurrence alone. This 
could be the result of the selection bias of this research, in which 
138 (53%) out of 269 patients who received operations were 
excluded from follow-up loss. In addition, difference in degrees of 
preoperative prolapse between the patients who were followed 
up and those who were not (most of the patients with advanced 
preoperative stage of prolapse were lost during the follow-up) [14]. 
Nieminen et al. [11] also concluded that the degree of preopera-
tive prolapse had little to do with the recurrence. Also, Tegerstedt 
and Hammarstrom [8] reported complicated delivery, urinary 
incontinence, and prior pelvic floor surgery to be the independent 
risk factors of recurrence, in contrast to the results by Nieminen et 
al. [11], Whiteside et al. [9] or our study. This could be explained 
by the fact that the study by Tegerstedt and Hammarstrom [8], as 
mentioned above, had a relatively longer follow-up period of 10 
to 12 years; (although many patients were lost during the follow-
up) [14]. 
History of surgery for POP and/or urinary incontinence at the time 
of primary surgery was associated with an increased postopera-
tive complications and risk of reoperation in two studies [17,18]. 
According to Maher et al. [19], there were insufficient data to al-
low evaluation of the impact of prolapsed surgery on continence 
issues. However, limited information suggested that concomitant 
TVT or Burch colposuspension might reduce postoperative incon-
tinence rates; this benefit needs to be balanced against possible 
differences in costs and adverse effects. Clark et al. [17] demon-
strated that having undergone previous POP and urinary inconti-
nence surgery increased the risk of reoperation to 17% compared 
with 12% for women who underwent a first procedure; moreover 
Denman et al. [18] observed the abdominal approach was protec-
tive against reoperation compared with the vaginal approach. 
Dällenbach et al. [7] suggested that POP severity did not increase 
the risk of complications and reoperation, and that neither did 
advancing age, BMI and vaginal deliveries, but suggested that the 
number of prolapsed vaginal wall segments and the absence of 
complete repair at initial surgery increased the risk of reoperation.
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It is nowadays widely accepted that underlying connective abnor-
malities, (in addition to hereditary factors), predispose to POP, and 
our study shows that they also predispose to POP recurrence [20-
23]. 
Nevertheless, we found that POP severity, expressed most dis-
tal preoperative POP stage, was associated with a significantly 
greater blood loss, and higher incidence rates of perioperative and 
long-term complications. Although the exact reason was not clear 
in the present study, we suggest that the risk of complication after 
POP surgery is associated with variables indicating preexisting 
weakness of pelvic floor tissues. 
Surgically treated prolapse represents the severe end of the 
spectrum of POP. The anatomical recurrence rate in our cohort 
is probably lower, at 30 women (7.5%); in most cases, women 
are asymptomatic and do not require surgery, 2 women (6.7%) 
among them underwent reoperation. In a cohort of 389 women 
who underwent POP vaginal repair, recurrence (stage 2 or more) 
was observed in 58% of the women after one year only [9]. How-
ever, only 9.7% had prolapsed protruding beyond the hymen. In 
another study, anatomical failure (vaginal wall prolapsed stage 2 
or more) was 31.3%, but only 7.4% had POP related symptoms 
[12].
We found significant lower rate of major complications requiring 
readmission or reoperation, which may be partly due to minimal 
use of mesh and the use of appropriate mesh; that is, ultralight-
weight polypropylene mesh.
Mesh complications such as chronic pelvic pain often happen with 
more serious and challenging problems, without any easy answer. 
Another factor is the technique for vaginal dissection. In this study, 
special concern was taken to achieve full-thickness dissection of 
the vaginal compartments after hydrodissection. This preserves the 
epithelial blood supply, and fully covers the mesh implant, which 
may influence mesh exposure. The role of vaginal dissection has to 
be assessed by further studies.
The strength of this study was that it compared POP-Q stage in-
cluding grade 2 with the incidence of perioperative complications 
and recurrence in women undergoing initial surgery for POP. In 
addition, the availability of a continuously updated computerized 
register, allowed us to identify cases and controls in the same 
large cohort with a long follow-up. More long-term studies that 
directly compare these three groups are required to support these 
findings definitively. 
The findings of this study may have been limited by several factors. 
The major weaknesses of this study were that it was retrospective 
in nature and had a small sample size. However, the percentage of 
follow-up loss was low (0%) compared with those of other stud-
ies. No patients were excluded from the analysis because records 
were not available or risk factors missing. We used the standard-
ized POP-Q system for the evaluation of prolapse and thoroughly 
investigated pelvic floor dysfunction and its complication. It is 
recommended that severity of prolapse take into account not only 
the stage of the most distal end but also the number of compart-
ments involved. However, our study did not consider the preopera-
tive POP substage and the number of prolapsed vaginal segments. 
Moreover, the overall perioperative complications and recurrence 
in women undergoing surgery for POP were rare (most were tran-
sient and reversible) and varied. Our own cohort was too small 
to draw any conclusion. We studied only distributions of compli-
cations. Finally, the impact of surgery on associated pelvic floor 
symptoms including bladder, bowel and sexual function, quality of 
life issues such as dyspareunia and patient satisfaction, cost, were 
not examined.
Additional prospective studies are needed to assess the effect of 
surgery in subgroups of women with different clinical and demo-
graphic characteristics. Large population-based long-term follow-
up studies on pelvic floor dysfunction are needed in the future to 
draw a more definite conclusion.
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골반장기탈출증의 각 병기에 따른 수술 후 합병증 및 재발률 비교
연세대학교 의과대학 1산부인과학교실, 2약리학교실
정연수1, 김수림1, 문여정2, 김세광1, 배상욱1 
목적
본 연구는 골반장기탈출증 환자에서 병기가 증가함에 따라 수술 후 합병증과 재발률이 증가하는지에 대해 알아보고자 하였다.
연구방법
2007년 1월부터 2010년 12월까지 본원 산부인과에서 골반장기탈출증으로 수술을 시행받은 국제요실금학회 골반장기탈출증 2기에서 4
기까지의 환자 중 기록분석이 가능한 399명의 환자를 대상으로 하였다. 골반장기탈출증 2기에서 4기까지 각 병기에 따른 환자들의 특성
과 재원일수, 신체질량지수, 기왕 수술력, 수술시간, 수술방법, 기저 질환, 수술 전 · 후의 혈색소 차이와 수술 후 합병증, 재발률에 대해 후향
적으로 조사하여 비교 분석하였다. 
결과
총 399명 중 2기 23명(5.8%), 3기 239명(70.5%), 4기 137명(34.3%)으로 병기가 높을수록 연령과 질식분만이 증가하였으나 통계학적으로 
유의한 상관관계는 보이지 않았다. 각 환자군에서 신체질량지수, 호르몬 치료 여부, 폐경 여부, 이전의 제왕절개술 및 수술력의 차이는 없
었다. 골반장기탈출증 4기 환자군에서 2, 3기 환자군에 비해 수술 후 합병증 발생이 유의하게 높았고(2개월 이내: 2기, 1명[4.3%]; 3기, 5
명[2.1%]; 4기, 12명[8.8%]; P = 0.010; 2개월 이후: 2기 1명[4.3%], 3기 8명[3.3%], 4기 13명[9.5%]; P = 0.041), 평균 수술시간 또한 병기
가 높아짐에 따라 유의하게 높게 나타났으며(2기, 84.7 ± 46.8분; 3기, 111.2 ± 66.2분; 4기, 146.4 ± 58.4분; P＜0.0001), 골반장기탈출
증 3기, 4기 환자군에서 재발률에 유의한 차이를 보였다(3기, 9명[3.8%]; 4기, 13명[9.5%]; P = 0.023). 수술 전후의 혈색소 차이와 수혈은 
통계학적으로 유의한 상관 관계가 없었다.
결론
골반장기탈출증 환자에서 병기가 증가함에 따라 수술 후 합병증 및 재발률이 증가하는 것으로 생각된다. 
중심단어: 골반장기탈출증, 골반장기탈출증 병기, 수술 후 합병증, 재발률 
